Six out of 14 NL gliomas would fulfill the most recent cIMPACT-NOW criteria for diffuse astrocytic glioma, IDH-WT, with molecular features of glioblastoma (grade IV). The gene discussed is IDH1; the disease is central nervous system cancer.